Target
Sigma non-opioid intracellular receptor 1
Ligand
BDBM50099823
Substrate
n/a
Meas. Tech.
ChEMBL_202070 (CHEMBL811340)
Ki
6.2±n/a nM
Citation
 Huang, YLuedtke, RRFreeman, RAWu, LMach, RH Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands. J Med Chem 44:1815-26 (2001) [PubMed]  Article 
Target
Name:
Sigma non-opioid intracellular receptor 1
Synonyms:
Aging-associated gene 8 protein | OPRS1 | SGMR1_HUMAN | SIG-1R | SIGMAR1 | SR-BP | SR31747-binding protein | SRBP | Sigma 1-type opioid receptor | Sigma opioid receptor | Sigma1R | hSigmaR1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
25124.85
Organism:
Homo sapiens (Human)
Description:
Q99720
Residue:
223
Sequence:
MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP
  
Inhibitor
Name:
BDBM50099823
Synonyms:
4-Bromo-1-methoxy-naphthalene-2-carboxylic acid (1-adamantan-2-yl-pyrrolidin-3-yl)-amide | CHEMBL51754
Type:
Small organic molecule
Emp. Form.:
C26H31BrN2O2
Mol. Mass.:
483.441
SMILES:
COc1c(cc(Br)c2ccccc12)C(=O)N[C@@H]1CCN(C1)C1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2 |wU:26.29,24.33,22.25,wD:28.32,16.17,TLB:19:21:23:26.30.25,THB:27:28:23:26.30.25,27:26:23:21.28.29,(6.46,-4.72,;7.8,-5.49,;7.81,-7.03,;9.14,-7.8,;9.14,-9.35,;7.81,-10.12,;7.8,-11.66,;6.48,-9.35,;5.14,-10.12,;3.82,-9.35,;3.82,-7.8,;5.14,-7.04,;6.48,-7.81,;10.47,-7.03,;10.46,-5.49,;11.79,-7.8,;13.12,-7,;13.1,-5.49,;15.76,-5.49,;15.76,-7.03,;14.45,-7.77,;17.08,-7.8,;18.27,-6.51,;18.27,-5.04,;19.61,-4.56,;21.01,-5.13,;20.99,-6.67,;19.99,-7.94,;18.58,-7.38,;18.58,-5.79,;19.6,-7,)|
Structure:
Search PDB for entries with ligand similarity: